Sponsor:
Dr. Anthony Ho
Code:
NCT02909322
Conditions
Pain Control After Elective Hepatectomy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Bupivacaine and Hydromorphone
Ropivacaine and Hydromorphone
Brief summary:
Conditions
Pain Control After Elective Hepatectomy
Study ID
NCT02909322
Start date
Apr, 2016
Status verified date
Dec, 2022
Completion date
Mar, 2023
Anticipated
Primary completion date
Mar, 2023
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Continuous Epidural Analgesia
experimental: Paravertebral Block Analgesia
Interventions
Bupivacaine and Hydromorphone
Ropivacaine and Hydromorphone
Primary outcome measure
Central contacts
Locations
Kingston General Hospital
Recruiting
Kingston, Ontario, Canada, K7L2V7
Contacts
Principal Investigator:
Anthony Ho, MD
Sponsor
Dr. Anthony Ho
Last update posted
Dec 5, 2022
Last verified
Dec, 2022
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Dr. Anthony Ho on 2022-12-05.